The General Hospital Corporation is recalling approximately 50 vials of Fludeoxyglucose F 18 Injection (20-300 mCi/mL). This prescription medication, which was manufactured by the Massachusetts General Hospital PET Center, is being recalled because of a lack of assurance of sterility. While no specific injuries or incidents have been reported, a lack of sterility in an injectable drug can lead to serious infections or other life-threatening complications. This recall affects 50 mL glass vials distributed to a single direct account in February 2021.
If an injectable drug is not sterile, it can introduce bacteria or other contaminants directly into the bloodstream or tissues, potentially causing severe systemic infections or sepsis.
Healthcare provider consultation and product refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.